RxDoctor Payments Data

Heidi Christie, DPM

Podiatrist · Montgomery, ALNPI 1629093042

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,616 of the $7,408 with a category attached, or 75.8%. Musculoskeletal Transplant Foundation Inc. accounts for 68.1% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $3,056 and has fallen 87.0% since, to $399 in 2025. Among podiatrist clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,408in general payments, 2019–2025

Across 118 payments — averaging $62.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Musculoskeletal Transplant Foundation Inc.$5K
  • Organogenesis Inc.$395
  • Paratek Pharmaceuticals, Inc.$341
  • AbbVie$197
  • Amgen$191
  • Vaporox, Inc.$167
  • plus $1K from 17 others

What the payments were for

  • Speaking & faculty fees$1472%
  • Travel & lodging$1,36618%
  • Food & beverage$5,61676%
  • Entertainment$2804%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,408 in reported general payments places this provider in the 90th percentile of 59 podiatrist providers in Alabama.

See all podiatrist providers in Alabama

Medicare billing

Part B allowed, 2024
$105,505
Medicare patients
312
Services billed
1,479

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole25$833
Diclofenac Sodium17$435
Gabapentin63$374
Clindamycin Hcl24$276
Doxycycline Hyclate21$238
Methylprednisolone11$130
Mupirocin13$83
Acetaminophen-CodeineAcetaminophen With Codeine14$48

Paid to pharmacies, not to this prescriber.

Other podiatrist in Montgomery

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →